Bibliografía
CARREY, E., R. J. AVERY, R. C. KNOWLES 1991 Chemotherapy of equine babesiosis. Journal American Vet. Med. Ass. 159. 1538-1545. FRERICHS W. M., A. A. HOLBROOK. 1992. Equine piroplasmosis. Complement. American Journal Vet. Res 172. 1992-1994. HENRY,M. Hemolytic Anemia. in Current Therapy in Equine Medicine Robisnon E. (ed) Cap 11, 495-501. 1997. HOLBROOK A.A. et al. Equine piroplasmosis. Intraerythrocytic development of Babesia caballi (Nuttal) and Babesia equi (Laveran). American Journal Veterinary Res. 29. 297-303. HOLBROOK A.A. et al. The biology of babesia: Development of the Babesia of horses. In: Bryant J.T. and H Gerber (eds): Equine Infectous Diseases II, 249-257- Basel: Karger. HOLBROOK A.A. et al. Laboratory diagnosis of equine piroplasmosis In: Bryant J.T. and H Gerber (eds): Equine Infectous Diseases III, 467-475. Basel: Karger. LOFSTEDT, JEANNE, Diagnostic Approach to Anemia, in Current Therapy in Equine Medicine 4 Robinson E. (ed) Cap V, 273-275. 1998. KIRKHAN W. W., 1996 The treatment of equine babesiosis. Journal Amercian. Vet. Med. Ass 155, 457-460. RISTIC M. 1998. Protozoal diseases. In Catcoot, E.J. (Eds) Equine Medicine and Surgery 2nd edition 137-155 Wheaton, III: American Veterinary Publications. ROBIN, R.L., J.C. WALLACE, C. J. BRUNNER ET AL, Inmuno-mediated haemolytic disease after penicillin therapy in a horse. Equine Vet. Journal, 25: 462-465, 2000. SCHIMIDT, G. R., G. HIRT, A. T. FISCHER,2000 Babesicidal effect of basically substitud carbanilides. I Res. Vet Sci, 10. 530-533. SELLON, D.C., Equine infectious anemia,Vet Clin. North Am.Equine Pract. 9(2):321-336. 1999. SELLON, D. C., Hemolytic Anemia. in Current Therapy in Equine Medicine 4 Robinson E. (ed) Cap V, 278-282.1998. TAYLOR W. M., C,F, SIMPSON AND F. G. MARTIN, 1993: certain aspects of toxicity of an anicarbalide formulation to ponies. American Journal Vet. Ass. Res 33, 533-541. TAYLOR W. M., C,F, SIMPSON AND F. G. MARTIN, 1996: chemotherapy of equine piroplasmosis, In Bryant J.T. and H Gerber (eds): Equine Infectous Diseases III, 476-483. Basel: Karger. |